List of Excipients in API treprostinil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing treprostinil
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | HYDROCHLORIC ACID | |
United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | METACRESOL | |
United Therapeutics Corporation | REMODULIN | treprostinil | 66302-101 | SODIUM CHLORIDE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing treprostinil
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 | HYDROCHLORIC ACID |
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 | METACRESOL |
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 | SODIUM CHLORIDE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for treprostinil
Excipient focus: ALCOHOL
treprostinil drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
treprostinil drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
treprostinil drug variants containing CELLULOSE ACETATE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing CELLULOSE ACETATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
treprostinil drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: FUMARYL DIKETOPIPERAZINE
treprostinil drug variants containing FUMARYL DIKETOPIPERAZINE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-616 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing FUMARYL DIKETOPIPERAZINE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
treprostinil drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
United Therapeutics Corporation | treprostinil | 66302-616 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
treprostinil drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
treprostinil drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
treprostinil drug variants containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: METACRESOL
treprostinil drug variants containing METACRESOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing METACRESOL
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-206 |
United Therapeutics Corporation | treprostinil | 66302-300 |
United Therapeutics Corporation | treprostinil | 66302-616 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
treprostinil drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
treprostinil drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
treprostinil drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
treprostinil drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
treprostinil drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
United Therapeutics Corporation | treprostinil | 66302-616 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
treprostinil drug variants containing SODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Alembic Pharmaceuticals Inc | treprostinil | 62332-514 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing SODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | treprostinil | 42023-209 |
DrReddy's Laboratories Inc | treprostinil | 43598-649 |
United Therapeutics Corporation | treprostinil | 66302-101 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
treprostinil drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
United Therapeutics Corporation | treprostinil | 66302-616 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
treprostinil drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
treprostinil drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
treprostinil drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
treprostinil drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
treprostinil drug variants containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | treprostinil | 42023-209 |
DrReddy's Laboratories Inc | treprostinil | 43598-649 |
United Therapeutics Corporation | treprostinil | 66302-101 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Alembic Pharmaceuticals Inc | treprostinil | 62332-514 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
treprostinil drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
DrReddy's Laboratories Inc | treprostinil | 43598-649 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Sandoz Inc | treprostinil | 0781-3420 |
United Therapeutics Corporation | treprostinil | 66302-300 |
United Therapeutics Corporation | treprostinil | 66302-616 |
>Company | >Ingredient | >NDC |
Excipient focus: XYLITOL
treprostinil drug variants containing XYLITOL
Company | Ingredient | NDC |
---|---|---|
United Therapeutics Corporation | treprostinil | 66302-300 |
>Company | >Ingredient | >NDC |
treprostinil drug variants not containing XYLITOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | treprostinil | 0703-0666 |
Sandoz Inc | treprostinil | 0781-3420 |
Par Pharmaceutical Inc | treprostinil | 42023-209 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.